EP2807192
Samsetning og aðferð til greiningar og meðhöndlunar á sjúkdómum sem tengjast taugahrörnun
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
25.1.2013EP published:
18.4.2018EP application number:
13703962.4
EP translation filed:
11.7.2018Grant published:
15.8.2018EPO information:
European Patent Register
Max expiry date:
24.1.2033Expiry date:
24.1.2026Next due date:
31.1.2026
Title:
COMPOSITION AND METHOD FOR DIAGNOSIS AND TREATMENT OF DISEASES ASSOCIATED WITH NEURITE DEGENERATION
Timeline
Today
25.1.2013EP application
18.4.2018EP Publication
11.7.2018Translation submitted
15.8.2018Registration published
24.1.2026Expires
Owner
Name:
Abbvie Deutschland GmbH & Co. KGAddress:
Max-Planck-Ring 2a, 65205, Wiesbaden, DE
Name:
AbbVie Inc.Address:
1 North Waukegan Road, 60064, North Chicago, IL, US
Inventor
Name:
MUELLER, BernhardAddress:
Neustadt-Gimmeldingen, DE
Name:
HUANG, LiliAddress:
Westford, Massachusetts, US
Name:
BARDWELL, Philip D.Address:
Boston, Massachusetts, US
Name:
KUTSKOVA, YuliyaAddress:
Northborough, Massachusetts, US
Name:
MEMMOTT, JohnAddress:
Framingham, Massachusetts, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201261591324 PDate:
27.1.2012Country:
US
Classification
Categories:
C07K 16/28, A61K 39/395, A61K 49/00, A61K 51/10, C07K 16/18, G01N 33/68, A61K 39/00, C07B 59/00, C07K 16/22
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 13.12.2018
Expires: 24.1.2020
Payer: Örn Þór, slf.
Number: 8
Paid: 17.12.2019
Expires: 24.1.2021
Payer: Örn Þór slf.
Number: 9
Paid: 16.12.2020
Expires: 24.1.2022
Payer: Örn Þór slf.
Number: 10
Paid: 21.12.2021
Expires: 24.1.2023
Payer: Árnason Faktor ehf.
Number: 11
Paid: 16.12.2022
Expires: 24.1.2024
Payer: Árnason Faktor ehf.
Number: 12
Paid: 20.12.2023
Expires: 24.1.2025
Payer: Árnason Faktor ehf.
Number: 13
Paid: 17.12.2024
Expires: 24.1.2026
Payer: Árnason Faktor ehf.